Press Releases

Company News
View Summary Oct 16, 2014
NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery Profiling
PDF 55.7 KB Add to Briefcase
View Summary Sep 29, 2014
NeoGenomics Appoints Robert J. Shovlin as Chief Operating Officer
PDF 11.9 KB Add to Briefcase
View Summary Sep 24, 2014
NeoGenomics Schedules its Q3 2014 Earnings Release for October 30, 2014
PDF 12.8 KB Add to Briefcase
View Summary Aug 22, 2014
NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option
PDF 12.2 KB Add to Briefcase
View Summary Aug 15, 2014
NeoGenomics Announces Pricing of $32.2 Million Public Offering
PDF 43.0 KB Add to Briefcase
View Summary Aug 14, 2014
NeoGenomics Announces Public Offering of Common Stock
PDF 12.3 KB Add to Briefcase
View Summary Jul 17, 2014
NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014
PDF 106.4 KB Add to Briefcase
View Summary Jul 16, 2014
NeoGenomics to Host Second Quarter 2014 Earnings Webcast Live on Thursday, July 17, 2014
PDF 12.2 KB Add to Briefcase
View Summary Jul 11, 2014
NeoGenomics Expands Next Generation Sequencing Services and Offers 23 Different Profiles for Various Hematologic and Solid Cancers
PDF 13.3 KB Add to Briefcase
View Summary Jul 8, 2014
NeoGenomics Completes Acquisition of Path Logic
PDF 65.2 KB Add to Briefcase
View Summary Jun 23, 2014
NeoGenomics Raises Guidance and Projects 30% Year-Over-Year Revenue Growth in Quarter 2, 2014
PDF 84.6 KB Add to Briefcase
View Summary Jun 18, 2014
NeoGenomics Schedules its Q2 2014 Earnings Release for July 17, 2014
PDF 13.4 KB Add to Briefcase
View Summary May 8, 2014
NeoGenomics Selected by Aurora Diagnostics as Primary Partner for Molecular, FISH, and Immunohistochemistry Testing
PDF 56.7 KB Add to Briefcase
View Summary Apr 23, 2014
NeoGenomics Reports Revenue of $18.2 Million and Adjusted EBITDA of $1.7 million for the First Quarter
PDF 123.2 KB Add to Briefcase
View Summary Apr 3, 2014
NeoGenomics Schedules its Q1 2014 Earnings Release for April 23, 2014
PDF 31.0 KB Add to Briefcase
View Summary Mar 18, 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
PDF 49.1 KB Add to Briefcase
View Summary Feb 19, 2014
NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013
PDF 33.2 KB Add to Briefcase
View Summary Jan 30, 2014
NeoGenomics Launches 22 New Cancer Genomic Tests Designed for Actionable Profiling of Various Hematologic and Solid Cancers
PDF 56.1 KB Add to Briefcase
View Summary Jan 17, 2014
NeoGenomics Schedules its Q4 2013 and Full Year 2013 Earnings Release for February 19, 2014
PDF 14.9 KB Add to Briefcase
View Summary Jan 7, 2014
NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms
PDF 58.2 KB Add to Briefcase
Showing 1-20 of 61 Page: 1 2 3 4  Next 20
Add to Briefcase = add release to Briefcase